PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium
Autism (“ASD”) is a global problem, with no generally accepted treatment. In the UK alone, between 1998 and 2018, research…
Autism (“ASD”) is a global problem, with no generally accepted treatment. In the UK alone, between 1998 and 2018, research…
D-Wave’s new go-to-market (“GTM”) growth strategy, initially focused on key verticals, including logistics, manufacturing, and government, is expected to accelerate…
Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in…
Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focused on acquiring value-add…
GEMXX (OTC: GEMZ), a mining and jewelry-making company, specializes in the mining of ammolite, a rare, opal-like gemstone that is…
PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”), is focusing its lead…
Eko2o S.A.S., a leader in sustainable agricultural technologies and a majority-owned subsidiary of Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana),…
FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has selected Counsel Public Affairs as its communications and marketing…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has…
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split…